Grigoriu BD - Search Results

1

[New diagnostic markers for malignant pleural mesothelioma].

Grigoriu BD, Grégoire M, Chahine B, Scherpereel A. Grigoriu BD, et al. Bull Cancer. 2008 Feb;95(2):177-84. doi: 10.1684/bdc.2008.0576. Bull Cancer. 2008. PMID: 18304902 Review. French.

2

Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.

Grigoriu BD, Scherpereel A, Devos P, Chahine B, Letourneux M, Lebailly P, Grégoire M, Porte H, Copin MC, Lassalle P. Grigoriu BD, et al. Clin Cancer Res. 2007 May 15;13(10):2928-35. doi: 10.1158/1078-0432.CCR-06-2144. Clin Cancer Res. 2007. PMID: 17504993

3

Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment.

Grigoriu BD, Chahine B, Vachani A, Gey T, Conti M, Sterman DH, Marchandise G, Porte H, Albelda SM, Scherpereel A. Grigoriu BD, et al. Am J Respir Crit Care Med. 2009 May 15;179(10):950-4. doi: 10.1164/rccm.200807-1125OC. Epub 2009 Feb 6. Am J Respir Crit Care Med. 2009. PMID: 19201924 Clinical Trial.

4

Clinical utility of diagnostic markers for malignant pleural mesothelioma.

Grigoriu BD, Grigoriu C, Chahine B, Gey T, Scherpereel A. Grigoriu BD, et al. Among authors: grigoriu c. Monaldi Arch Chest Dis. 2009 Mar;71(1):31-8. doi: 10.4081/monaldi.2009.374. Monaldi Arch Chest Dis. 2009. PMID: 19522163 Review.

5

Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.

Scherpereel A, Grigoriu BD, Noppen M, Gey T, Chahine B, Baldacci S, Trauet J, Copin MC, Dessaint JP, Porte H, Labalette M. Scherpereel A, et al. Among authors: grigoriu bd. BMC Cancer. 2013 Jul 2;13:324. doi: 10.1186/1471-2407-13-324. BMC Cancer. 2013. PMID: 23816056 Free PMC article.

6

Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma.

Scherpereel A, Grigoriu B, Conti M, Gey T, Grégoire M, Copin MC, Devos P, Chahine B, Porte H, Lassalle P. Scherpereel A, et al. Am J Respir Crit Care Med. 2006 May 15;173(10):1155-60. doi: 10.1164/rccm.200511-1789OC. Epub 2006 Feb 2. Am J Respir Crit Care Med. 2006. PMID: 16456138

7

Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma.

Grigoriu B, Chahine B, Zerimech F, Grégoire M, Balduyck M, Copin MC, Devos P, Lassalle P, Scherpereel A. Grigoriu B, et al. Clin Biochem. 2009 Jul;42(10-11):1046-50. doi: 10.1016/j.clinbiochem.2009.03.007. Epub 2009 Mar 18. Clin Biochem. 2009. PMID: 19302997 Free article.

8

Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis.

Hollevoet K, Reitsma JB, Creaney J, Grigoriu BD, Robinson BW, Scherpereel A, Cristaudo A, Pass HI, Nackaerts K, Rodríguez Portal JA, Schneider J, Muley T, Di Serio F, Baas P, Tomasetti M, Rai AJ, van Meerbeeck JP. Hollevoet K, et al. Among authors: grigoriu bd. J Clin Oncol. 2012 May 1;30(13):1541-9. doi: 10.1200/JCO.2011.39.6671. Epub 2012 Mar 12. J Clin Oncol. 2012. PMID: 22412141 Free PMC article. Review.

9

Diagnostic value of soluble mesothelin in malignant mesothelioma.

Grigoriu BD, Scherpereel A. Grigoriu BD, et al. Thorax. 2008 Jan;63(1):87-8; author reply 87. Thorax. 2008. PMID: 18156575 No abstract available.

10

Screening for malignant mesothelioma--looking for the holy grail.

Grigoriu B, Scherpereel A. Grigoriu B, et al. Am J Respir Crit Care Med. 2009 May 1;179(9):851; author reply 851-852. doi: 10.1164/ajrccm.179.9.851. Am J Respir Crit Care Med. 2009. PMID: 19383930 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters